Ortho-Clinical Diagnostics

Type: Company
Name: Ortho-Clinical Diagnostics
First reported Aug 29 2014 - Updated Aug 29 2014 - 2 reports

Why J&J Wants to Divest Medical Devices Business

Big old-school conglomerates are selling. First it was Dow Chemical, Merck and General Electric putting up units for sale. Now its Johnson & Johnson, the world’s biggest maker of health-care products, that is seeking a buyer for its medical devices b ... [Published Yahoo! Finance - Aug 29 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson

In a report published Friday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Johnson & Johnson (NYSE: JNJ[1]).In the report, Morgan Stanley noted, “The Wall Street Journal is reporting that J&J is seeking a buyer for Cordis, ... [Published DailyMe.Com - Aug 29 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 2 reports

Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson

In a report published Friday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Johnson & Johnson (NYSE: JNJ).In the report, Morgan Stanley noted, “The Wall Street Journal is reporting that J&J is seeking a buyer for Cordis, a ... [Published Benzinga.com - Aug 29 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

3 Points Showing Why Medtech is Having a Great 2014 So Far

Postedin Medical Device Business by Arundhati Parmar on August 20, 2014A new report reviewing the first six months of the year paints an optimistic picture of the medtech industry.2013 was a year when M&A activity, VC funding and regulatory approvals ... [Published Medical Device & Diagnostic Industry - Aug 20 2014]
First reported Aug 11 2014 - Updated Aug 11 2014 - 1 reports

Sphere Medical : Prof JL Vincent joins Medical Advisory Board

Sphere Medical Holding plc("Sphere Medical" or the "Company")Professor Jean-Louis Vincent joins Medical Advisory Board~ Appointment of World Authority on Critical Care Medicine ~Cambridge, UK, 11 August 2014: Sphere Medical Holding plc (AIM: SPHR.L), ... [Published 4 Traders - Aug 11 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Carlyle: Europe, Japan Price Discount Too Great to Ignore

Carlyle Co-Founders and Co-Chief Executives William Conway (left) and David Rubenstein.Bloomberg News/Simon Dawson Carlyle Group LP, which has been investing capital more quickly this year than many of its peers, believes bargains lie in Europe and ... [Published WSJ.com: Private Equity Beat - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Ortho-Clinical Diagnostics, Inc. Collaborates with Astute Medical, Inc.

Ortho-Clinical Diagnostics, Inc. (OCD) announced that it has entered into a strategic partnership with Astute Medical, Inc., to develop and commercialise Astute’s NEPHROCHECK® Test and ASTUTE140® Meter in certain markets in Europe.The NEPHROCHECK® Test ... [Published Asian Hospital & Healthcare Management - Jul 30 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Carlyle closing in on Acosta deal - report

(M&A Navigator via COMTEX News Network) -- 29 July 2014 - US private equity investor The Carlyle Group LP (NASDAQ:CG) is poised to strike a deal with sector player Thomas H Lee Partners LP for the acquisition of Florida-based retail marketing company ... [Published PredictWallStreet - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 6 reports

Ortho-Clinical Diagnostics and Astute Medical to Develop Acute Kidney Injury Tests

Ortho-Clinical Diagnostics has entered into a strategic partnership with Astute Medical, under which OCD will become the exclusive commercial partner for the distribution of Astute’s NEPHROCHECK ® Test and ASTUTE140 ® Meter in certain markets in Europe ... [Published PharmaceuticalProcessing - Jul 28 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Ortho-Clinical Diagnostics, Inc. Announces Executive Leadership Additions as It Becomes an Independent, Stand-Alone Company

RARITAN, N.J.--(BUSINESS WIRE)--Today Ortho-Clinical Diagnostics, Inc. (OCD) unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group (NASDAQ: CG) from Johnson & Johnson. ... [Published Business Wire Health News - Jul 08 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

J&J completes divestiture of Ortho-Clinical Diagnostics business to Carlyle Group

Johnson & Johnson has completed the divestiture of its Ortho-Clinical Diagnostics business to The Carlyle Group for approximately $4 billion, subject to customary adjustments.Under the terms of the transaction, The Carlyle Group has acquired the Ortho-Clinical ... [Published PharmaBiz - Jul 02 2014]
First reported Jun 16 2014 - Updated Jun 16 2014 - 1 reports

Robert Yates to be named COO of Carlyle’s OCD

The Carlyle Group has selected Robert Yates as chief operating officer of Ortho-Clinical Diagnostics subject to the close of Carlyle’s acquisition of OCD from Johnson & Johnson . In this newly-created role, Yates will report directly to incoming ... [Published PE Hub Blog - Jun 16 2014]

Quotes

"Recent actions follow the promotion of the Biosense Webster management team to run Cardiovascular and Pharma executives taking a more active role in overseeing Device innovation. Trimming lower growth, less innovative assets, such as OCD and Cordis, will help the overall growth profile of the Device segment. In our view, management remains interested in certain segments of the device market but we would not see this potential action as a signal they are looking to aggressively expand the device footprint with large, low return M&A. The company has not commented on this report.”"
Two other top deals of the year, aside from Proteus' gigantic haul are HeartFlow's $104.7 million Series C round and Adaptive Biotechnologies " $100 million Series D round, the report noted."
Professor Vincent added: "Proxima has the potential to bring about a paradigm shift in the intensive and critical care setting. I look forward to working closely with the MAB and contributing to Proxima's future success following its commercial launch in the near future."
"Astute's innovative approach and product is a perfect fit with the commercial strength of OCD and our desire to advance important new diagnostic tests" commented Dr. Martin D Madaus , OCD chairman and chief executive officer

More Content

All (50) | News (24) | Reports (0) | Blogs (22) | Audio/Video (0) | Fact Sheets (1) | Press Releases (3)
sort by: Date | Relevance
J&J looks to sell off Cordis for as much as $2B [Published FierceMedicalDevices - Aug 29 2014]
Why J&J Wants to Divest Medical Devices Business [Published Yahoo! Finance - Aug 29 2014]
Report: J&J puts Cordis on the block [Published MassDevice - Aug 29 2014]
Morgan Stanley Sees More Focused Device Strateg... [Published DailyMe.Com - Aug 29 2014]
Morgan Stanley Sees More Focused Device Strateg... [Published Benzinga.com - Aug 29 2014]
Johnson and Johnson Plans To Divest Its Cordis ... [Published Bidness Etc - Aug 29 2014]
Johnson & Johnson to seek buyer for medical dev... [Published CNBC - Aug 29 2014]
Future Horizons and Growth Strategies in the US... [Published Global Information Inc - Aug 26 2014]
3 Points Showing Why Medtech is Having a Great ... [Published Medical Device & Diagnostic Industry - Aug 20 2014]
Sphere Medical : Prof JL Vincent joins Medical ... [Published 4 Traders - Aug 11 2014]
Hologic's (HOLX) CEO Stephen MacMillan on Q3 20... [Published Seeking Alpha - Jul 31 2014]
Carlyle: Europe, Japan Price Discount Too Great... [Published WSJ.com: Private Equity Beat - Jul 30 2014]
Ortho-Clinical Diagnostics, Inc. Collaborates w... [Published Asian Hospital & Healthcare Management - Jul 30 2014]
Carlyle closing in on Acosta deal - report [Published PredictWallStreet - Jul 29 2014]
Ortho-Clinical Diagnostics and Astute Medical t... [Published PharmaceuticalProcessing - Jul 28 2014]
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published The CW44 Tampa Bay - Jul 28 2014]
Astute Medical And Ortho-Clinical Diagnostics E... [Published Vision Monday - Jul 28 2014]
Astute Medical And Ortho-Clinical Diagnostics E... [Published PR Newswire: Health - Jul 28 2014]
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Technology News - Jul 28 2014]
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Health News - Jul 28 2014]
Johnson & Johnson Reports 2014 Second-Quarter R... [Published HispanicBusiness.com - Jul 23 2014]
Innovator Liability at 100 [Published Drug and Device Law - Jul 18 2014]
Ortho-Clinical Diagnostics, Inc. Announces Exec... [Published Business Wire Health News - Jul 08 2014]
J&J completes divestiture of Ortho-Clinical Dia... [Published PharmaBiz - Jul 02 2014]
Johnson & Johnson Completes Divestiture Of Orth... [Published Financial Services - Jun 30 2014]
The 5 Most-Loved Stocks This Quarter [Published Wall St. Cheat Sheet - Jun 20 2014]
Robert Yates to be Named Chief Operating Office... [Published GlobeNewswire: Acquisitions News - Jun 16 2014]
Robert Yates to be named COO of Carlyle’s OCD [Published PE Hub Blog - Jun 16 2014]
Research and Markets: Global HIV-AIDS Testing M... [Published Business Wire Health News - May 15 2014]
Carlyle Says It’s Still A Seller’s Market, But ... [Published WSJ.com: Private Equity Beat - Apr 30 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Carlyle: Europe, Japan Price Discount Too Great... [Published WSJ.com: Private Equity Beat - Jul 30 2014]
Carlyle Co-Founders and Co-Chief Executives William Conway (left) and David Rubenstein.Bloomberg News/Simon Dawson Carlyle Group LP, which has been investing capital more quickly this year than many of its peers, believes bargains lie in Europe and ...
Astute Medical And Ortho-Clinical Diagnostics E... [Published PR Newswire: Health - Jul 28 2014]
SAN DIEGO, July 28, 2014 /PRNewswire/ -- Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. (OCD) that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury ...
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Technology News - Jul 28 2014]
RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. has entered into a strategic partnership with Astute Medical, Inc. to become the exclusive commercial partner of Astute’s NEPHROCHECK® Test and ASTUTE140® Meter. ...
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Health News - Jul 28 2014]
RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. has entered into a strategic partnership with Astute Medical, Inc. to become the exclusive commercial partner of Astute’s NEPHROCHECK® Test and ASTUTE140® Meter. ...
Innovator Liability at 100 [Published Drug and Device Law - Jul 18 2014]
This post is only from the Reed Smith (more properly, the non-Dechert) side of the blog.One hundred what, you say?Certainly not years; the awful Conte v. Wyeth, Inc., 85 Cal. Rptr.3d 299, (Cal. App. 2008), decision just turned six – this blog is older ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Johnson & Johnson Completes Divestiture Of Orth... [Published Financial Services - Jun 30 2014]
Robert Yates to be Named Chief Operating Office... [Published GlobeNewswire: Acquisitions News - Jun 16 2014]
Johnson & Johnson Announces Acceptance Of Bindi... [Published Financial Services - Mar 31 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.